NDC11 70748023706
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70748-0237-06 | 70748-0237 |
| 70748-0237-6 | 70748-0237 |
| 70748-237-06 | 70748-237 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azilsartan medoxomil | AZILSARTAN MEDOXOMIL | Lupin Pharmaceuticals, Inc. | b1c8de43-3b26-408f-8c7e-6c7d76348199 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 70748-237-06 70748-237 70748023706 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.